Advanced search×

Evaluation of a Canadian back pain mass media campaign.

Douglas P Gross, Anthony S Russell, Robert Ferrari, Michele C Battié, Donald Schopflocher, Richard Hu, Gordon Waddell, and Rachelle Buchbinder

Spine (Phila Pa 1976) 35(8):906-13 (2010) PMID 20308943

Quasi-experimental before-and-after design with control group.

DOI: 10.1097/BRS.0b013e3181c91140
Version: za2963e q8zaa q8zb2 q8zce q8zdb q8ze9 q8zf8 q8zgb
Buy PDF

Similar articles you may find interesting…

  1. Outcome measures and their measurement properties for trapeziometacarpal osteoarthritis: a systematic literature review.
    M Marks, J W Schoones, and T P M Vliet Vlieland

    J Hand Surg Eur Vol (2013) PMID 23649014

    We first identified studies including TMC OA patients and extracted all outcome measures. They were categorized according to the Outcome Measures in Rheumatology (OMERACT) core set for OA including five dimensions: pain, physical function, global assessment, imaging, and quality of life (QoL). Secon...
    Buy PDF
  2. Circulating secreted frizzled-related protein 5 and wingless-type MMTV integration site family member 5a levels in patients with type 2 diab...
    Yung-Chuan Lu, Chao-Ping Wang, and Yau-Jiunn Lee

    Diabetes Metab Res Rev (2013) PMID 23653377

    A total of 82 patients with T2DM and 42 non-diabetic subjects were studied. Plasma Sfrp5 levels were found to be elevated in patients with T2DM (9.4 ± 9.0 vs. 7.4 ± 10.9 ng/mL, P = 0.006). In contrast, Wnt5a levels were decreased (6.8 ± 12.6 vs. 9.1 ± 4.0 ng/dL, P < 0.001). Increasin...
    Buy PDF
  3. Subantimicrobial-dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages.
    Aino Salminen, Pirkko J Pussinen, and Timo Sorsa

    Inflamm Res (2013) PMID 23649042

    Our results suggest that SDD treatment may reduce the risk of cardiovascular disease in this patient group by increasing the cholesterol efflux capacity of serum....
    Buy PDF